Effect of diet-induced weight loss on cytokeratin-18 levels in overweight and obese patients with liver fibrosis (original) (raw)
Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
Rafiz Abdul Rani
International journal of hepatology, 2018
View PDFchevron_right
948 Identification of Biomarkers That Measure Disease Activity in Patients with Nonalcoholic Fatty Liver Disease
k bhaskar
Journal of Hepatology, 2008
View PDFchevron_right
Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
Kaname Yoshizawa, Akihiro Matsumoto
Journal of Clinical Gastroenterology, 2010
View PDFchevron_right
Role of Serum Ck-18 Fragment, Alanine Transaminase and Aspertate Transaminase Level in the Assessment of Fatty Liver Diseases
Debatosh Paul
2015
View PDFchevron_right
Cytokeratin 18 Fragment Level is a Useful Biomarker in Predicting Steatosis and NASH But Not Fibrosis
Pankaj Asati
Journal of Clinical and Experimental Hepatology, 2016
View PDFchevron_right
Serum Cytokeratin 18 M30 Antigen Level and Its Correlation with Nutritional Parameters in Middle-Aged Japanese Males with Nonalcoholic Fatty Liver Disease (NAFLD)
Takayo Kawakami
Journal of Nutritional Science and Vitaminology, 2010
View PDFchevron_right
Serum Levels of CK18 M30 and Leptin Are Useful Predictors of Steatohepatitis and Fibrosis in Paediatric NAFLD
Anil Dhawan
Journal of Pediatric Gastroenterology and Nutrition, 2010
View PDFchevron_right
Association of Serum Cytokeratin-18 Fragment Concentration in Patients with Different Types of Nonalcoholic Fatty Liver Disease
Tuhin sultana
Gastroenterology & Hepatology : Open Access, 2015
View PDFchevron_right
The Effect of Moderate Weight Loss on a Non-Invasive Biomarker of Liver Fibrosis: A Randomised Controlled Trial
Nerys Astbury
Obesity Facts, 2020
View PDFchevron_right
Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
Nizar Zein
Hepatology, 2009
View PDFchevron_right
Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study
Rosa Morillas
Frontiers in Endocrinology
View PDFchevron_right
Reply to: “Non-invasive prediction of fibrosis in nonalcoholic fatty liver disease”
Eduardo Fassio
Journal of Hepatology, 2011
View PDFchevron_right
Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients
Lisa Yerian
Clinical Gastroenterology and Hepatology, 2008
View PDFchevron_right
Cytokeratin 18, a Marker of Cell Death, Is Increased in Children With Suspected Nonalcoholic Fatty Liver Disease
Swati Joshi-barve
Journal of Pediatric Gastroenterology and Nutrition, 2008
View PDFchevron_right
Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease
Maha El Brashy
View PDFchevron_right
Novel Plasma Biomarkers Associated with Liver Disease Severity in Adults with Nonalcoholic Fatty Liver Disease
Katherine Yates
Hepatology, 2016
View PDFchevron_right
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population
Vlad Ratziu
Journal of Hepatology, 2012
View PDFchevron_right
Expression of NF‐κB, IL‐6, and IL‐10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD—Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple‐blind randomized controlled clinical trial
Maryam Saghafi-asl
Journal of Cellular Physiology, 2020
View PDFchevron_right
Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
Elvira del Pozo Maroto
Clinical Gastroenterology and Hepatology, 2019
View PDFchevron_right
Analytical, anthropometric and dietary factors associated with the development of fibrosis in patients with nonalcoholic fatty liver disease
Natalia Serrano Mora
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, 2018
View PDFchevron_right
The role of serum cytokeratin 18 and platelet count as non-invasive markers in the diagnosis of nonalcoholic fatty liver disease in children with type 1 diabetes mellitus
Yasser Elhosary
2020
View PDFchevron_right
Association of Serum Cytokines with Liver Fibrosis as Measured by Computerized Morphometry across Diseases of NAFLD Spectrum
Sasha Stoddard
2017
View PDFchevron_right
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Giulio Marchesini
Hepatology, 2007
View PDFchevron_right
Anti-inflammatory diet consumption reduced fatty liver indices
Yahya Pasdar
Scientific Reports, 2021
View PDFchevron_right
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
Stephen Stewart
Gut, 2010
View PDFchevron_right
Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
Anni Poikola
The Journal of Clinical Endocrinology & Metabolism
View PDFchevron_right
Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD)
Surasak Saokaew
Medicine, 2016
View PDFchevron_right
Screening for advanced liver fibrosis in overweight and obese patients with NAFLD
Metabolism and Target Organ Damage
Metabolism and Target Organ Damage, 2022
View PDFchevron_right
Relationship between changes in serum keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease
Katherine Yates
2016
View PDFchevron_right